The SURPASS-2 head-to-head trial of semaglutide vs tirzepatide in type 2 diabetes — what the data actually showed and how to interpret it.
Three major brand-adjacent GLP-1 telehealth services — Ro, Weight Watchers, and LifeMD — compared on structure, cost, and fit.
Ozempic and Wegovy contain the same active ingredient. Here's what actually differs — indications, dosing, coverage, and program structures.
NovoCare and LillyDirect cash-pay programs compared — pricing, eligibility, delivery, and which fits which patient.
Multi-month prepay vs month-to-month billing for compounded GLP-1s — true 12-month cost math and when each fits.
Injectable vs oral tirzepatide compared — efficacy expectations, monthly cost, format experience, and which fits which patient profile.
GLP-1 medications vs phentermine — the old and new of pharmacologic weight loss, compared on efficacy, safety, cost, and use case.
Embody vs Wellorithm — two compounded injectable semaglutide providers compared on pricing, focus, and fit.
Compounded vs brand injectable semaglutide — full cost-of-ownership comparison including hidden costs, continuity risks, and total spend.
Compounded tirzepatide vs compounded semaglutide compared on cost, availability, and fit for different patient profiles.
Head-to-head comparison of Wegovy vs Zepbound in 2026 — study data, real-world evidence, and how the two brand-name GLP-1s actually compare.
Wegovy and Saxenda are both Novo Nordisk weight-loss GLP-1s. Here's how they compare and why Wegovy has largely superseded Saxenda.
Wegovy pill vs injectable Wegovy compared six months after pill launch — real-world availability, cost, efficacy, and which fits which patient.
Telehealth-bundled vs pharmacy-direct GLP-1 access compared — cost breakdown, support structure, and which fits which patient.
Sleeve gastrectomy vs tirzepatide compared in 2026 — weight loss magnitudes, durability, cost, risk, and how the two treatments now overlap and diverge.
How swallowed tablets, sublingual dissolvables and liquid drops differ in practice, and which providers offer each format at what price.
What GLP-1 providers charge in year two, which ones publish a maintenance rate at all, and how to estimate the ones that do not.
Which GLP-1 telehealth providers bundle coaching, anti-nausea medication or supplements, and which of those extras are actually worth paying for.
How long each step of GLP-1 telehealth onboarding takes, where the delays actually occur, and which provider models are structurally faster.
Why compounded GLP-1 vials differ in concentration and fill volume between providers, and why that difference is a dosing-safety issue.
A fixed-budget comparison — set the price at $200 a month and see exactly what medication, format and support each provider gives you for it.
How online GLP-1 telehealth pricing compares against in-person weight clinics and brand-name self-pay programs as of late 2026.
Comparing the real cost difference between semaglutide and tirzepatide when you match them by clinical dose tier rather than by headline price.
What each GLP-1 telehealth provider requires before prescribing — BMI thresholds, lab work, and the conditions that rule you out.
A July 2026 JAMA study found 45 of 49 GLP-1 telehealth platforms had minimal clinical oversight. Here's the actual breakdown, not the sanitized version.
Many GLP-1 telehealth 'brands' are storefronts owned by the same parent company. Here's how to actually check ownership before assuming independent competition.
The advertised GLP-1 price is rarely your real cost. Here's every line item to add up before comparing providers.
What happens to your money if a GLP-1 medication doesn't work for you? Here's what to actually ask before your first order.
Provider comparisons that never get updated mislead readers. Here's our accountability update on what's actually changed since our last review cycle.
Fast GLP-1 approval isn't automatically a red flag - but it can be. Here's how to tell legitimate efficiency from skipped clinical review.
Telehealth platforms rarely specify whether an MD or NP reviews your case. Here's the actual distinction and what to ask before you commit.
Some GLP-1 providers charge a separate membership fee. Here's what it's actually supposed to cover and how to tell if it's worth it.
Running the full twelve-month arithmetic on GLP-1 providers, including intro rates, dose escalation, billing cycles and shipping.
A dose-by-dose price comparison of compounded semaglutide across the major telehealth providers, including which ones charge the same at every dose.
A comparison of subscription mechanics across GLP-1 telehealth providers — renewal timing, pause availability, cancellation windows and refund posture.
Viral GLP-1 TikTok hacks fact-checked. Apple cider vinegar, microdosing, injection site tricks, and other social media weight loss claims examined.
GLP-1 influencer disclosure practices vary widely. Here's what's actually required and how to spot content that isn't playing it straight.
Many GLP-1 telehealth companies are newer than their polished branding suggests. Here's how to check a provider's actual operating history in two minutes.
No legitimate GLP-1 provider can ethically guarantee your results. Here's why that specific marketing claim is a genuine red flag.
FDA warning letters are public record and one of the most useful provider-evaluation signals nobody checks. Here's what they mean and how to check them yourself.
Provider review sites are easy to manipulate. Here's how to actually spot fake or incentivized reviews versus genuine ones.
GLP-1 marketing is full of unsourced statistics. Here's how to actually tell verifiable claims from spin in under a few minutes.
Some GLP-1 pricing structures create a financial incentive for faster dose escalation. Here's what to watch for and how to ask about it directly.
Compounded and brand-name GLP-1 marketing both distort the comparison in their favor. Here's what's actually different, stripped of the spin.
BBB and state AG records are free, public, and rarely checked. Here's what a five-minute search actually reveals about a provider.
Every provider promises a personalized treatment plan. We investigated what 'personalized' actually means — and what it doesn't.
We read the cancellation terms of every major GLP-1 program. Some let you walk away anytime. Others make Planet Fitness look flexible.
We tested response times, escalation paths, and whether you can actually reach a human when something goes wrong.
Supply chain reports from the front lines. Which providers are shipping on time and which are stalling — and what that means for your treatment.
Both formats work. Neither is universally better. Here's what the evidence actually says — without the spin.
Our quarterly assessment of the GLP-1 telehealth market. Which providers raised their standards — and which ones slipped.
The way your provider bills you affects more than your bank account. It shapes your flexibility, your risk, and your options if things change.
Dozens of GLP-1 telehealth companies have already closed or pivoted. If yours is next, here's what happens to your treatment.
Lab work is the clearest signal of whether your provider is practicing medicine or just shipping medication. Here's what the best programs require.
Any provider that guarantees you'll lose a specific number of pounds is violating medical ethics. Here's what legitimate programs say instead.
Auto-refill schedules don't always match your actual usage. Here's how to avoid paying for medication you haven't used yet.
We tried to independently verify the compounding pharmacy behind each major GLP-1 program. Some made it easy. Others made it impossible.
Same molecule, very different products. Here's the honest comparison the industry doesn't want you to see.
Life changes. Your treatment needs change. Does your provider let you adapt — or do they penalize you for it?
There's a massive gap between 'ongoing medical support' in the marketing and what actually happens after your first shipment arrives.
The FDA's regulatory actions on 503B outsourcing facilities are reshaping the compounded GLP-1 market. Some providers saw it coming. Others didn't.
When can you expect to see results on semaglutide, tirzepatide, or orforglipron? We compare timelines from clinical trial data.
Every provider promises results. We looked at what they actually deliver — and where the gaps are.
Most GLP-1 patients hit a plateau between months 6-12. Here's the science behind it and evidence-based strategies to push through.
GLP-1 weight regain after stopping medication. STEP extension data, discontinuation rates, and why regain doesn't invalidate treatment.
Nausea, fatigue, constipation — most GLP-1 side effects are temporary. But these symptoms require immediate medical attention.
Are compounded GLP-1 medications counterfeit? Understanding 503A and 503B compounding pharmacies, FDA regulations, and legitimate vs illegitimate sources.
15-20% of GLP-1 patients are non-responders. Here's why it happens and what your options are if you're not losing weight.
GLP-1 medications vs phentermine comparison. Mechanism, efficacy, safety, cost, and duration of treatment differences explained.
GLP-1 medications slow gastric emptying, which can change how other drugs are absorbed. These interactions matter most.
We read the terms of service so you don't have to. What we found should change how you compare GLP-1 programs.
GLP-1 medications treat both type 2 diabetes and obesity, but the prescribing approach differs. Here's what matters for each indication.
Zepbound vs Mounjaro: same tirzepatide molecule with different FDA labels, pricing, and insurance coverage. What actually differs.
Rapid weight loss on GLP-1s can weaken bones. Women over 50 face the highest risk. Here's what to monitor and how to protect yourself.
Wegovy vs Ozempic comparison: same semaglutide molecule, different doses, different insurance coverage. The real differences explained.
Exercise plus GLP-1 preserves muscle, boosts metabolism, and may improve long-term outcomes. Here's what the evidence supports.
GLP-1 medication vs bariatric surgery comparison with real efficacy data, cost analysis, and long-term outcome research for 2026.
Your compounded GLP-1 comes from either a 503A or 503B pharmacy. The distinction affects quality, regulation, and future availability.
Telehealth is faster and cheaper. In-person gives you lab work and physical exams. Here's how to decide which is right for your situation.
Semaglutide (Wegovy/Ozempic) vs tirzepatide (Zepbound/Mounjaro): efficacy, side effects, cost, and availability compared for June 2026.
The advertised GLP-1 price is rarely the full cost. Here's what commonly shows up at checkout that the homepage number doesn't mention.
Most GLP-1 ads show starting-dose prices. Here's what you'll actually pay at maintenance dose across 12 telehealth providers.
A new value metric for comparing GLP-1 providers: cost per percentage point of body weight lost. Real math comparing telehealth pricing.
Medicare Part D beneficiaries can access GLP-1 medications for $50/month starting July 1. Here's how the Bridge program works and who qualifies.
Eli Lilly's TRIUMPH-1 data shows retatrutide delivers 28% weight loss — rivaling bariatric surgery. What this triple agonist means for the future.
LegitScript certification separates vetted telehealth providers from the rest. Here's what it verifies and which GLP-1 platforms have it.
Signing up for a GLP-1 provider is instant. Canceling isn't always. Here's what to check before you commit.
With Foundayo, oral semaglutide, and injectable options all available, choosing a GLP-1 format matters. We compare efficacy, cost, and convenience.
Switching GLP-1 providers doesn't mean starting over. Here's how to transfer your prescription, maintain your dose, and avoid gaps.
Is compounded semaglutide equivalent to Wegovy or Ozempic? FDA regulations, 503A vs 503B pharmacies, and what the evidence shows.
Men respond differently to GLP-1 medications — faster initial loss, different side effect profiles, and unique muscle preservation needs.
GLP-1 'as low as' pricing almost always refers to your first month at the lowest dose. Here's what your actual maintenance-dose cost will be.
Not all GLP-1 telehealth providers are equal. These five red flags signal you should look elsewhere before committing.
New NIH research reveals the molecular pathways behind GLP-1 weight loss — and why some patients respond better than others.
GLP-1 medications suppress appetite, but skipping protein accelerates muscle loss. Here's how much you need and why it matters.
Many GLP-1 users report dramatically reduced alcohol tolerance and cravings. Here's what the research says and what to watch for.
Your titration schedule affects your results and your side effects. Not all providers handle it the same way — and the differences matter.
Eli Lilly's oral GLP-1 pill Foundayo starts at $149/mo. Compounded semaglutide starts at $99-159/mo. We compare the real costs at every stage.
Berberine vs Ozempic and GLP-1 medications: clinical evidence comparison. Is berberine really 'nature's Ozempic'? The data examined.
What to expect in your first 30 days on semaglutide or tirzepatide — from side effects to appetite changes to your first weigh-in.
GLP-1 treatment isn't a 3-month fix — it's ongoing therapy. Here's how to calculate the real annual cost and find sustainable options.
The FDA proposes permanently excluding semaglutide, tirzepatide, and liraglutide from 503B bulk compounding. Comment period closes June 29, 2026.
Two GLP-1 pills, different trade-offs. Oral semaglutide has higher efficacy but strict fasting rules. Foundayo is flexible but less potent.
Compounded GLP-1s cost 60-80% less but aren't FDA-approved. Brand-name versions have clinical trial backing. Here's how to choose.
Oxford's BMJ meta-analysis found weight regain of 0.9 lbs/month after stopping GLP-1s. Here's what the data says — and how to plan for it.
New real-world data from ASCO 2026 shows GLP-1 medications may reduce metastatic progression in lung, breast, colorectal, and liver cancers.
775+ adverse events from compounded GLP-1. Here's how to tell if your telehealth provider is legitimate — and when to walk away.
Eli Lilly's triple-hormone drug is the most effective weight loss medication ever tested. It's also 2+ years away. Here's why starting now is smarter.
Two GLP-1 pills, very different rules. We compare orforglipron (Foundayo) and oral Wegovy on dosing, efficacy, convenience, and pricing.
SideBySideMeds verification methodology. How we verify telehealth provider claims, check pricing, and maintain editorial independence.
May 2026 NIH study: oral GLP-1 pills suppress eating for pleasure via deep brain pathways. Different mechanism than injectables.
Sublingual semaglutide drops vs oral semaglutide tablets compared. Compounded vs FDA-approved needle-free GLP-1 options.
CMS launches $50/mo GLP-1 access for Medicare July 2026. We read every line of the announcement so you don't have to.
Pooled side-effect rates from STEP and SURMOUNT trials comparing semaglutide and tirzepatide. Real clinical data, not anecdotes.
Most sites show starting prices. We show what you'll actually pay at maintenance dose. Complete GLP-1 pricing at every titration step.
Oral vs injectable GLP-1 efficacy comparison. Wegovy pill vs injection, Foundayo vs injectable semaglutide. Clinical trial data compared.
Prices dropped, pills launched, Medicare joined. The competitive landscape for GLP-1 medications has never been more favorable for patients.
The April 30, 2026 FDA proposal to remove GLP-1s from the 503B Bulks List. We break down who benefits, who loses, and what it means for your medication.
Do GLP-1 medications cause muscle loss? DXA body composition data from STEP and SURMOUNT trials analyzed. The muscle loss myth examined.
Compounded GLP-1 costs 50-80% less than brand. But is it the same medication? We compare cost, safety, legality, and efficacy with actual numbers.
75-80% weight maintenance sounds good. But what about the 20-25% you lose? We analyze the ATTAIN-MAINTAIN data honestly.